
Heterocyclic Communications p. 7 - 16 (2001)
Update date:2022-07-30
Topics:
Jennings, Sharon A.
Toth, James L.
Roller, Shane G.
Brooks, Natalie
O'Hare, Caroline
Kiakos, Konstantinos
Hartley, John A.
Burke, Philip J.
Lee, Moses
An efficient method for the preparation of racemic seco-cyclopropaneindoline, or seco-CI, analogs of the anticancer agent CC1065 is described. The syntheses of seco-CI compounds containing either 5,6,7-trimethoxyindole-2-carbonyl, 4, or 5-(benzofuran-2-carboxamido)indole-2-carbonyl, 10, or 2-(4-N,N-diethyl)aminophenyl)benzimidazole-6-carbonyl, 11, or 4-(4-butanamido-1-methylpyrrole-2-carboxamido)-1-methylpyrrole-2-carbonyl, 12, subunit are detailed. At μM concentrations, compounds 4, 10-12 inhibited the growth of human leukemic K562 cells in culture.
View MoreShanghai PurityPE Biotechnology Co., Ltd.
website:http://www.puritype.com
Contact:+86-18917347808; +86-15921887593
Address:Room 907, Tongda Venture Building, No.1, Lane 600, Tianshan Road, Shanghai, China
Shijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
Hangzhou Cherry Pharmaceutical Technology Co., Ltd.
Contact:+86 (571) 8163-6070 / +86 18042403330
Address:262Wangtang Road
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Wuxi Zuping Food Science And Technology Co.,LTD.
Contact:+86-510-87210822
Address:Guanlin town
Doi:10.1016/S0022-328X(00)00942-6
(2001)Doi:10.1016/j.molcata.2016.05.031
(2016)Doi:10.7164/antibiotics.24.767
(1971)Doi:10.1021/ja01145a050
(1951)Doi:10.1016/0039-128X(63)90016-3
(1963)Doi:10.1021/jm00276a013
(1972)